Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors

European Journal of Pharmacology

Volumn 380, Issue 2-3, 1999, Pages 197-202

  Fredholm, Bertil B ^a   Lindström, Karin ^a  

^a Sect Molec Neuropharmacology   (Sweden)

Author keywords

Adenosine receptor; Autoradiography; Cortex; Striatum; Xanthine

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CHLORO 4 CYCLOHEXYLAMINO 1 (TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3A]QUINOXALINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; HUMAN; NEUROMODULATION; PRIORITY JOURNAL; RADIOASSAY;

ADENOSINE; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; CAFFEINE; MALE; PHENETHYLAMINES; PYRAZINES; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; TRIAZINES; TRIAZOLES; TRITIUM; XANTHINES;

EID: 0032853403     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00533-6     Document Type: Article

References (29)

1. 2A adenosine receptor in four PC12 cell clones. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;28-32.
2. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett. 4:1994;2539-2544.
3. 2A receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;261-271.
4. 1-receptors in rat brain, as revealed by autoradiography. Neuroscience. 34:1990;759-769.
5. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22:1987;813-826.
6. 1 receptor-mediated mechanisms. Eur. J. Neurosci. 8:1996;1545-1553.
7. Fredholm B.B. Purinoceptors in the nervous system. Pharmacol. Toxicol. 76:1995;228-239.
8. 2A adenosine receptor antagonist, is a useful ligand in autoradiographic studies J. Neurochem. 70:1998;1210-1216.
9. 1 MF-2 smooth muscle cells. Mol. Pharmacol. 40:1991;149-155.
10. 2-selective adenosine antagonists. J. Med. Chem. 36:1993;1333-1342.
11. 2 receptors in rat brain J. Pharmacol. Exp. Ther. 251:1989;888-893.
12. Johansson B., Parkinson F.E., Fredholm B.B. Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 in rat striatum. Biochem. Pharmacol. 44:1992;2365-2370.
13. 2 adenosine receptor binding and on mRNA levels. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;407-414.
14. 3H ]CGS 21680 to rat cortex differs from its binding to rat striatum Eur. J. Pharmacol., Mol. Pharmacol. Sect. 247:1993;103-110.
15. Kenakin T. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol. Sci. 18:1997;456-464.
16. Klotz K.-N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;1-9.
17. 2 receptor antagonist. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 267:1994;335-341.
18. Ongini E., Dionisotti S., Gessi S., Irenius E., Fredholm B.B. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;7-10.
19. 3H ]-CGS 21680 as a ligand Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;85-89.
20. 1 receptors: a complicating factor in quantitative autoradiography. J. Neurochem. 58:1992;941-950.
21. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol. 1:1992;179-186.
22. Paxinos, G., Watson, W., 1986. The rat brain in stereotaxic coordinates, 2nd edn., Academic Press, London.
23. 2a selective adenosine receptor antagonist. Br. J. Pharmacol. 115:1995;1096-1102.
24. Sarges R., Howard H.R., Browne R.G., Lebel L.A., Seymour P.A., Koe B.K. 4-Amino:1,2,4:triazolo:4,3-a:quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J. Med. Chem. 33:1990;2240-2254.
25. 2 antagonists. J. Med. Chem. 35:1992;2342-2345.
26. 1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol. Pharmacol. 53:1998;886-893.
27. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 80:1997;1171-1185.
28. Svenningsson P., Nomikos G.G., Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci. 19:1999;4011-4022.
29. Williams M., Francis J., Ghai G., Braunwalder A., Psychoyos S., Stone G.A., Cash W.D. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. J. Pharmacol. Exp. Ther. 241:1987;415-420.